BSTG Stock Chart

Biostage is a biotechnology company developing bio engineered organ implants based on its novel Cellframe technology. The Company's Cellframe technology is comprised of a biocompatible scaffold seeded with the patient’s own stem cells. Biostage is pursuing the Cellspan esophageal implant as its first product candidate to address esophageal atresia and esophageal cancer and is also developing its technology’s applications to address conditions of the bronchus and trachea.